4.7 Review

Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection

Journal

LANCET NEUROLOGY
Volume 14, Issue 6, Pages 640-654

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(15)00009-5

Keywords

-

Funding

  1. Emil Aaltonen Foundation
  2. Maud Kuistila Memorial Foundation
  3. Helsinki University Central Hospital Research Fund
  4. Biomedicum Helsinki Foundation
  5. Helsinki University Medical Foundation
  6. BMS
  7. Pfizer
  8. Bayer
  9. Boston Scientific
  10. Boehringer Ingelheim
  11. Johnson and Johnson
  12. Lundbeck
  13. Mitsubishi Pharma
  14. H Lundbeck A/S
  15. Sanofi-Aventis
  16. PhotoThera Inc
  17. BrainsGate
  18. Orion Pharma
  19. Schering Plough
  20. Concentric Medical
  21. Helsinki University Central Hospital
  22. Sigrid Juselius Foundation
  23. Liv och Halsa Foundation
  24. Biocenter Finland
  25. Biocentrum Helsinki
  26. European Union
  27. Finnish Academy of Sciences
  28. National Institutes of Health
  29. Professio Finland
  30. University of Helsinki
  31. Finnish Medical Association
  32. Finnish Neurological Association
  33. University of Donau (Krems)
  34. Salus Ansvar Foundation Award
  35. Finnish Medical Association Quality Award
  36. European Stroke Conference
  37. European Federation of Neurological Societies Conference
  38. European Stroke Organisation
  39. University of Rostock
  40. University of Bielefeld, Australia
  41. New Zealand Stroke Society
  42. Austrian Stroke Society
  43. University of Leuven
  44. University of Tarto
  45. Nordic Stroke Conference
  46. Polish Neuroscience Society
  47. Greek Internal Medicine Society
  48. University of Donau, Krems
  49. Thrombolysis and Thrombectomy Acute Stroke Treatment Conference
  50. World Stroke Conference
  51. University of Bern
  52. University of Tuebingen
  53. German Psychological Society
  54. Covidien
  55. Swiss National Science Foundation
  56. Swiss Heart Foundation
  57. SHIRE
  58. Nestle Health Services
  59. Agence Nationale de la Recherche
  60. Dutch Heart Foundation [2007/B45]
  61. National Institute of Health [U10 NS086606-01]
  62. American Heart Association/American Stroke Association (AHA/ASA) National Clinical Research Program [AHA 3CRP141400001]
  63. National Institute of Health and Research senior investigator award

Ask authors/readers for more resources

Spontaneous intracranial artery dissection is an uncommon and probably underdiagnosed cause of stroke that is defined by the occurrence of a haematoma in the wall of an intracranial artery. Patients can present with headache, ischaemic stroke, subarachnoid haemorrhage, or symptoms associated with mass effect, mostly on the brainstem. Although intracranial artery dissection is less common than cervical artery dissection in adults of European ethnic origin, intracranial artery dissection is reportedly more common in children and in Asian populations. Risk factors and mechanisms are poorly understood, and diagnosis is challenging because characteristic imaging features can be difficult to detect in view of the small size of intracranial arteries. Therefore, multimodal follow-up imaging is often needed to confirm the diagnosis. Treatment of intracranial artery dissections is empirical in the absence of data from randomised controlled trials. Most patients with subarachnoid haemorrhage undergo surgical or endovascular treatment to prevent rebleeding, whereas patients with intracranial artery dissection and cerebral ischaemia are treated with antithrombotics. Prognosis seems worse in patients with subarachnoid haemorrhage than in those without.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available